VC Firm Versant Ventures Closes In On $300 Million Fund For Medtech And Biotech
Published: Jul 09, 2014
Versant Ventures, a California-based venture capital firm with a history of investing millions in Minnesota health care companies, has closed on $295 million for a new fund, according to a regulatory filing.
The firm, which opened a Twin Cities office in 2012, said in a regulatory filing last year it was seeking $250 million for its fifth fund. A late June filing sets a target of $300 million, which is about $200 million less than the West Coast firm's previous fund.
Help employers find you! Check out all the jobs and post your resume.